E-commerce platform Amazon has rolled out their online medicine supply chain management in India, starting in Bengaluru, that will aim to suffice the needs of the buyers to order medicine online and get them delivered at their doorstep.
With the new announcement, U.S e-commerce giant plans to deliver medicines are a natural extension of its wide logistics network and customer reach. For starters, the company has started the program in Bengaluru first.
“As a part of our commitment to fulfilling the needs of customers, we are launching the new Amazon Pharmacy in Bengaluru allowing customers to order prescription based medication,” an Amazon spokesperson said.
Starting with the new announcement, the company is also aiming to deliver over-the-counter medicines, basic health devices, and Ayurveda medication from the certified sellers in the country and deliver the best possible aid to the consumer.
By their new mechanism, the e-commerce company, Amazon India, will aim towards providing a helping hand to their customers who can now meet their essential needs, all with the ease of easy online buying processes and staying safe at home.
In the past few months, the medical industry saw an uprise in its production and distribution chains. Online pharmacies have seen orders spike as much as 50 percent in the last three months during the COVID-19 pandemic.
During this period, people have stayed at home more than ever. Practicing social distancing and consuming daily essentials such as hand sanitizers and masks, this surge in orders has improved the economics of numerous brands in India.
Now, with an unaltered market and an upcoming opportunity for years to come, more e-commerce companies are striving to conquer the market while several outsiders have also jumped into the e-commerce business to gain the weight.
Also read- Individuals With H-1B Visa Can Re-enter USA Under Certain Conditions
Recently, Mukesh Ambani led Reliance Industries to close down the deal to buy out the Chennai-based Netmeds, a medicinal company, for about $200 million. Also, the two biggest names, PharmEasy and Medlife are also exploring a possible merger.
This unannounced merger will land the e-pharma giant PharmEasy to acquire its rival between $120 to $150 million. 1mg, another player in the space, backed by investors such as Sequoia, has also held conversations with these players, according to media reports.
With all the above buyouts going on that adds with a rapid shift in the industry, all the Indian domain companies could announce their respective dealings in the upcoming months and will mark new pathways into the digital e-commerce market in the country.